Insider Transactions in Q2 2025 at Natera, Inc. (NTRA)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 24
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
755
-0.5%
|
$114,760
$152.46 P/Share
|
|
Apr 23
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
495
-0.64%
|
$74,250
$150.74 P/Share
|
|
Apr 22
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+1.6%
|
-
|
|
Apr 22
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
911
-0.6%
|
$131,184
$144.83 P/Share
|
|
Apr 21
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
86
-0.02%
|
$12,470
$145.85 P/Share
|
|
Apr 21
2025
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
470
-0.1%
|
$68,150
$145.85 P/Share
|
|
Apr 21
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
296
-0.1%
|
$43,216
$146.2 P/Share
|
|
Apr 21
2025
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct |
343
-0.11%
|
$49,735
$145.82 P/Share
|
|
Apr 21
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
1,664
-0.42%
|
$241,280
$145.81 P/Share
|
|
Apr 21
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
610
-0.4%
|
$88,450
$145.85 P/Share
|
|
Apr 20
2025
|
Jonathan Sheena |
BUY
Exercise of conversion of derivative security
|
Direct |
190
+0.07%
|
-
|
|
Apr 20
2025
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
856
+0.38%
|
-
|
|
Apr 20
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
3,386
+1.66%
|
-
|
|
Apr 20
2025
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,521
+1.94%
|
-
|
|
Apr 04
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
3,070
-0.24%
|
$411,380
$134.09 P/Share
|
|
Apr 03
2025
|
Jonathan Sheena |
SELL
Open market or private sale
|
Indirect |
3,000
-0.81%
|
$417,000
$139.28 P/Share
|
|
Apr 01
2025
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
3,000
-0.7%
|
$420,000
$140.79 P/Share
|
|
Apr 01
2025
|
Gail Boxer Marcus |
SELL
Open market or private sale
|
Direct |
4,000
-6.55%
|
$564,000
$141.14 P/Share
|
|
Apr 01
2025
|
Gail Boxer Marcus |
BUY
Exercise of conversion of derivative security
|
Direct |
4,000
+13.38%
|
$64,000
$16.14 P/Share
|
|
Apr 01
2025
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
15,898
-1.92%
|
$2,225,720
$140.74 P/Share
|